IntusCare upgrades IRIS risk-adjustment platform for PACE programmes

IntusCare's revamped IRIS system gives elderly-care providers a real-time end-to-end view of Medicare risk-adjustment data and revenue.

By Disrupts Editorial Team Thu, 22 October 2026 AI level 2 of 5

AI level 2 of 5: drafted by our AI editorial assistant from the company's announcement; fact-checked, edited and signed off by Mark Walker, Editorial Director. What the levels mean

A brightly lit, modern hallway features glass walls displaying server racks, flanked by stainless steel doors with digital access panels, and a closed door at the far end.

IntusCare, a healthcare technology company focused exclusively on Programs of All-inclusive Care for the Elderly (PACE), has released a major upgrade to its Intus Revenue Integrity System, known as IRIS. The enhanced platform connects coding validation, risk-adjustment analytics and payment reconciliation into a single daily-updated dashboard, giving PACE organisations continuous visibility over the journey from a clinician's diagnosis entry through to the final Medicare payment.

PACE programmes occupy a specific and financially sensitive corner of the US healthcare system. They serve dual-eligible seniors, individuals qualifying for both Medicare and Medicaid, who receive bundled medical and social services while remaining at home rather than entering institutional care. In return, PACE organisations receive a monthly Medicare capitation payment calibrated to each participant's risk adjustment factor (RAF) score: a higher score for a sicker patient means higher reimbursement. Because clinical, eligibility and financial records have historically sat in separate systems, errors or documentation gaps have often gone undetected until after the Centers for Medicare and Medicaid Services (CMS) submission window closed, leaving revenue on the table.

Closing the documentation gap

The original IRIS, launched in 2024, began addressing this fragmentation by combining the three data streams. The 2026 upgrade deepens the integration, updating records daily so teams can pinpoint precisely where a diagnosis or submission has stalled, assess the potential revenue impact and calculate how much time remains before the CMS correction window expires. Malissa Bolish, director of risk adjustment strategy at IntusCare, described the use case plainly: "A change in a risk score or payment is the starting point for an investigation. Teams need to understand what caused that change, whether it requires action, and how much time they have to respond."

IntusCare says IRIS has been deployed across more than 30 PACE organisations nationwide. Among those that have used the platform for over a year, the company reports an average 5% improvement in RAF scores, a figure that carries direct revenue significance given that PACE budgets are driven almost entirely by capitation. The general availability of the upgraded version is expected in November 2026, pending beta results, with additional enhancements, including cost data for margin calculations and participant-level revenue projections, planned for 2027.

Macro context: software eating specialist healthcare finance

The IRIS upgrade sits within a broader structural shift in healthcare administration. Across the US payer and provider landscape, the convergence of clinical workflow software with revenue-cycle management and regulatory compliance tooling is accelerating. What was once a series of manual reconciliation tasks spread across billing teams is being absorbed into real-time analytics platforms, a pattern already well established in acute-care hospital systems and now propagating into community-based models such as PACE.

For cross-sector investors watching the senior-care technology space, the dynamics are notable. The US dual-eligible population, individuals enrolled in both Medicare and Medicaid, numbers roughly 12 million people and represents a disproportionate share of total programme spend. PACE, while still a relatively small slice of that market, is expanding as state Medicaid agencies look for cost-effective alternatives to nursing-home placement. That growth trajectory makes PACE-specific infrastructure software an increasingly attractive vertical within the broader healthcare IT stack. IntusCare's positioning as the self-described only end-to-end ecosystem built specifically for PACE programmes reflects a deliberate niche-ownership strategy: capture the workflow layer of a government-funded, capitation-financed market before it scales. Whether the company pursues external capital to accelerate that position, it has not disclosed funding details in this release, is a question investors in adjacent healthtech verticals will likely be asking as the 2027 feature roadmap takes shape.